BioXcel's Ch. 11 Stayed Securities Settlement, Judge Says
By Clara Geoghegan · October 5, 2026, 7:16 PM EDT
BioXcel Therapeutics' Chapter 11 filing paused a securities class action against it, a Delaware bankruptcy judge ruled Monday, after a federal court had pressed the life sciences group for a more...
To view the full article, register now.